XML 47 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Active Partner Companies by Segment (Detail)
Jan. 31, 2013
Sotera Wireless, Inc.
Feb. 28, 2013
Pneuron, Inc.
Jun. 30, 2013
Healthcare
AdvantEdge Healthcare Solutions, Inc.
Jun. 30, 2013
Healthcare
Alverix, Inc.
Jun. 30, 2013
Healthcare
Crescendo Bioscience, Inc.
Jun. 30, 2013
Healthcare
Good Start Genetics, Inc.
Jun. 30, 2013
Healthcare
Medivo, Inc.
Jun. 30, 2013
Healthcare
NovaSom, Inc.
Jun. 30, 2013
Healthcare
NuPathe
Jun. 30, 2013
Healthcare
PixelOptics, Inc.
Jun. 30, 2013
Healthcare
Putney, Inc.
Jun. 30, 2013
Healthcare
Sotera Wireless, Inc.
Jun. 30, 2013
Technology
AppFirst, Inc.
Jun. 30, 2013
Technology
Beyond.com, Inc
Jun. 30, 2013
Technology
Bridgevine, Inc.
Jun. 30, 2013
Technology
DriveFactor Inc.
Jun. 30, 2013
Technology
Hoopla Software, Inc.
Jun. 30, 2013
Technology
Lumesis, Inc.
Jun. 30, 2013
Technology
MediaMath, Inc.
Jun. 30, 2013
Technology
Pneuron, Inc.
Jun. 30, 2013
Technology
Spongecell, Inc.
Jun. 30, 2013
Technology
ThingWorx, Inc.
Schedule Of Equity Method Investments [Line Items]                                            
Ownership interest under equity method, percentage 7.70% 27.60% 40.20% 49.20%   30.00% 34.50% 30.30%   24.60% 27.60%   35.00% 38.30% 22.50% 35.40% 25.30% 44.20% 22.20% 27.60% 23.10% 39.80%
Ownership interest under cost method, percentage         12.60%             7.40%                    
Ownership interest under fair value method, percentage                 16.60% [1]                          
[1] The Company's ownership interest in NuPathe was accounted for as available-for-sale securities following NuPathe’s completion of an initial public offering in August 2010. In October 2012, the Company participated in a private placement of NuPathe preferred stock units, and in conjunction with this financing, the Company placed two persons on NuPathe's board of directors. As a result, the Company determined that it exercised significant influence over NuPathe which made the equity method of accounting applicable to its ownership interests. Instead, the Company elected the fair value option beginning in October 2012. Prior to August 2010, the Company accounted for NuPathe under the equity method.